Obstructive sleep apnea has been linked to an increased risk of dementia in a new study—and the association was particularly ...

Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance Company’s dual go-to-market strategy ...

Along with an Alzheimer’s diagnosis comes a flood of questions, both for the person with the disease and their family. The uncertainty of a future with Alzheimer’s is ...

The European Union's drugs regulator reversed its decision to block the Alzheimer's drug lecanemab, a treatment aimed at ...

Dementia, a term encompassing a decline in cognitive function, is a complex and often misunderstood condition. More than 55 ...

DEMENTIA can cause a number of physical changes in a person – but some of these changes could appear years before a diagnosis ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Cannabis is emerging as a tool in dementia care, offering relief from anxiety and agitation when traditional medications fall ...

Dementia strikes all races, but new research suggests thinking declines in poor seniors are often overlooked.Among a ...

She's spent many hours doing research and speaking with other caregivers to find her way to resources designed to help ...

In 2022, The Tulsa Opera partnered with a program called Songs By Heart that works to bring live, interactive, music therapy ...

We fully endorse the Editorial1 on the negative opinion of the European Medicines Agency of the use of lecanemab for the treatment of early Alzheimer's disease. Investigators from the European ...